Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | MME | P08473 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | ESRRB | O95718 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31516115 | 0.80 | ALDH1A1 (0.39) | SMN1; SMN2 | |
| SCHEMBL2403903 | 0.80 | SMN1; SMN2 (0.37) | SMN1; SMN2CA14CA12MMECA1 | |
| SCHEMBL14353547 | 0.78 | SMN1; SMN2 (0.35) | SMN1; SMN2CA14CA12MMECA1 | |
| SCHEMBL5535077 | 0.77 | ALDH1A1 (0.33) | — | |
| SCHEMBL14354416 | 0.75 | SMN1; SMN2 (0.33) | SMN1; SMN2CA14 | |
| Hydrochloric Acid SCHEMBL9797867 | 0.74 | SMN1; SMN2 (0.33) | SMN1; SMN2CA1CA2 | |
| SCHEMBL1387254 | 0.73 | — | — | |
| SCHEMBL5701101 | 0.73 | — | — | |
| SCHEMBL10487218 | 0.72 | SMN1; SMN2 (0.32) | SMN1; SMN2 | |
| SCHEMBL24072865 | 0.72 | SMN1; SMN2 (0.46) | SMN1; SMN2CA14CA12MMECA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0266978-A2 | Novel antibacterial agents and potentiators of carbapenem antibiotics | MERCK & CO. INC. (US) | 1988-05-11 | — | — | EP | disclosed |